Contract SPE2D220D0089
Puracap Laboratories Llc · Department Of Defense · April 29, 2020
Puracap Laboratories Llc was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on April 29, 2020 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 10 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on May 6, 2025. If all options are exercised, the contract could reach $13.80 million.
Contract details
- PIID
- SPE2D220D0089
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- April 29, 2020
- Latest action
- May 6, 2025
Description
4610056409!MANUFACTURE/DISTRIBUTOR BR-PH
Modification timeline
-
May 6, 2025Mod P00012$0
-
May 21, 2024Mod P00010$0
-
March 5, 2024Mod P00009$0
-
July 27, 2023Mod P00008$0
-
July 10, 2023Mod P00007$0
-
April 10, 2023Mod P00006$0
-
April 25, 2022Mod P00005$0
-
March 22, 2021Mod P00004$0
-
August 10, 2020Mod P00003$0
-
May 18, 2020Mod P00002$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2D220D0089?
Contract SPE2D220D0089 is a federal contract awarded to Puracap Laboratories Llc by Department Of Defense on April 29, 2020 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 10 times since the base award.
Who won contract SPE2D220D0089?
Puracap Laboratories Llc won contract SPE2D220D0089 from Department Of Defense.
How much is contract SPE2D220D0089 worth?
Contract SPE2D220D0089 has obligated $0 to date but carries a potential ceiling of $13.80 million if fully funded and all options are exercised.